Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats.
D000311:Adrenal Glands / Q000502:physiology; D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D000242:Cyclic AMP / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011433:Propranolol / Q000494:pharmacology; D011719:Pyrazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology
D001593:Benzyl Compounds; D002395:Catecholamines; D007093:Imidazoles; D008738:Methyl Ethers; D010726:Phosphodiesterase Inhibitors; D011719:Pyrazines; D011743:Pyrimidines; D014230:Triazoles; D003994:Bucladesine; D004176:Dipyridamole; D011433:Propranolol; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D007545:Isoproterenol; D000420:Albuterol; D004837:Epinephrine